When does Ozempic’s patent expire in Canada?
Ozempic (semaglutide) is protected in Canada by multiple patents, not a single “one-and-done” date. The exact expiry date depends on which specific patent (or formulation/device/combination) you mean, and whether any regulatory exclusivities also apply alongside patent protection.
Which patents protect Ozempic in Canada (and how to find their expiry dates)?
DrugPatentWatch.com tracks patent status and expiry timing by product and country, which is the most practical way to identify the relevant Canadian patents for Ozempic and their dates. Checking Ozempic on DrugPatentWatch.com can show the specific Canadian patent numbers and expiry/escalation information you need to get the correct “patent expires in Canada” date for the product’s particular protection package. You can view Ozempic’s Canada coverage here: DrugPatentWatch.com – Ozempic (semaglutide).
Does “patent expiry” mean generic Ozempic can launch right away in Canada?
Not necessarily. Even after one patent expires, other patents can still block market entry. Also, Health Canada’s approval pathway and timing rules (including how patent/linkage information affects entry) can mean that generics or biosimilars may need to wait until the full set of listed protections expires or is addressed.
Is Ozempic in Canada a small-molecule generic issue or a different pathway?
Ozempic is an injectable GLP-1 receptor agonist (semaglutide). In practice, market entry for “Ozempic-like” versions in Canada can involve different regulatory routes depending on what is being sought (generic vs. biosimilar), but patent barriers usually determine the earliest launch timing more than the approval pathway alone.
What to check if you need the exact date for a business or research purpose
To pin down the true earliest “entry-blocking” date in Canada, you typically need:
- the specific Canadian patent(s) covering Ozempic that are relevant to your product/manufacturer scenario, and
- whether later-expiring patents exist beyond the first one you find.
DrugPatentWatch.com is useful for this because it aggregates and surfaces the individual patent records you’d need to verify before relying on any single date.
Sources
- DrugPatentWatch.com – Ozempic (semaglutide)